Berberine vs. Ozempic: Is this natural supplement effective for Weight Loss?

Berberine, often called ‘‘nature’s Ozempic’’ has been making waves online for quite some time (though I’ll admit, I’m a bit late to the trend). A quick scroll through TikTok or Instagram will show influencers mixing up ‘‘nature’s Ozempic cocktails’’ and touting claims that it can melt body fat, balance blood sugar, and even help with PCOS.

But what’s the truth behind the hype? Is berberine truly a natural alternative to GLP-1 medications like Ozempic, or are we just witnessing another social media trend with inflated promises?

In this blog post, we will look into the science behind berberine and GLP-1 medications, exploring how they work, the limitations of berberine, and what else can help increase GLP-1 naturally. We’ll also look at practical ways to support your body’s insulin production and balance blood sugar without relying on supplements.

Table of contents:

• What is Ozempic and Berberine

• Ozempic versus Berberine

• What the science says about both

• The challenges and limitations of Berberine

• Other ways to stimulate GLP-1 production and improve Insulin sensitivity

• Supplements that can influence GLP-1 Levels

• Final thoughts and takeaways

What is Ozempic and Berberine ?

Berberine is a compound extracted from various plants, including around 24 species such as European barberry, goldenseal, and Indian barberry. It has a long history of use in traditional Chinese and Ayurvedic medicine, particularly for treating digestive issues ¹. 

Ozempic (semaglutide) is a prescription medication classified as a GLP-1* (glucagon-like peptide-1) receptor agonist. It is FDA-approved for managing type 2 diabetes and, more recently, for weight management under the brand name Wegovy. Ozempic and Wegovy are not the only GLP-1 medications; others include Saxenda, Mounjaro, Victoza, and more.

*GLP-1 is a hormone in your body that helps control blood sugar and hunger. It signals your pancreas to produce insulin after you eat and suppresses glucagon secretion, preventing unnecessary glucose production and keeping blood sugar levels in check. Additionally, GLP-1 slows down how quickly your stomach empties and helps you feel full, so you eat less ².

GLP-1 impacts the brain, stomach, and pancreas by regulating appetite, slowing gastric emptying, and enhancing insulin secretion.

---

Ozempic versus Berberine: 

Berberine and Ozempic work in completely different ways. Berberine activates an enzyme called AMP-activated protein kinase (AMPK), which plays a key role in how your body manages energy. It also inhibits an enzyme called PCSK9 ( PCSK9 affects how much cholesterol stays in your bloodstream), which may help remove more LDL cholesterol from your bloodstream ³. This can improve insulin sensitivity, lower blood sugar, and support healthy cholesterol levels, though researchers are still uncovering exactly how it works.

On the other hand, Ozempic mimics a natural hormone called GLP-1, which helps regulate blood sugar and appetite. It slows down how quickly your stomach empties, reduces hunger, and helps the body produce more insulin. Unlike berberine, Ozempic acts on the hypothalamus, a brain region that controls hunger and satiety ⁴.

Another key difference is how they are taken: Ozempic is an injectable medication, while berberine is taken orally. Ozempic is also much more expensive, especially if it’s not covered by your insurance, whereas berberine is far more accessible, typically costing $10–$30 and available online or at health food stores. Additionally, Ozempic’s high cost and prescription-only status make it less accessible to the general population, whereas berberine can be purchased easily without a prescription.

Ozempic’s effects are well-studied and understood, making it a reliable medical option for managing diabetes and weight, while berberine is a natural supplement with promising, though less researched, benefits.

What the science says about Ozempic and Berberine

BERBERINE

Studies analyzing the effects of berberine show some benefits. Berberine may improve insulin sensitivity, lower blood pressure, reduce triglycerides and cholesterol, and aid in weight loss for those with metabolic disorders. It also shows potential benefits for hormonal health in PCOS and may help reduce inflammation markers like c-reactive protein (CRP). However, more high-quality research is needed to confirm these effects ⁵ ⁶ ⁷ ⁸.

OZEMPIC (SEMAGLUTIDE)

Semaglutide has proven to be incredibly effective for weight loss, with studies showing an average reduction of 10.09% (10.54 kg) to 11.80% (12.2 kg) in body weight for individuals with obesity or overweight. It works by reducing appetite and  energy intake, which not only leads to weight loss but also improves key health markers like blood pressure, cholesterol, inflammation (CRP), blood sugar (HbA1c), and waist circumference. The most common side effects are gastrointestinal issues, such as nausea, vomiting, diarrhea, and constipation. 

Interestingly, a systematic review and meta-analysis involving 3,962 overweight or obese adults without diabetes suggests that while semaglutide is effective on its own, combining it with lifestyle interventions such as behavioral therapy and dietary changes may enhance its impact ⁹ ¹⁰.

The challenges and limitations of Berberine

GLP-1 medications like Ozempic and Wegovy are strictly regulated and FDA-approved. In contrast, berberine supplements are not, which raises concerns about their safety. These supplements could be dangerous, as they may be contaminated, contain substances other than berberine, or lack proper labeling (since consumers cannot verify their contents).

Berberine can cause side effects such as nausea and vomiting and may interact with medications, particularly those metabolized by the liver. It is also unsafe for pregnant or breastfeeding individuals and young children.

Additionally, berberine can lead to hypoglycemia (extremely low blood sugar), especially when combined with other blood sugar-lowering medications.

Berberine-drug interactions should not be overlooked, as it can diminish the effects of medications like blood thinners and antihypertensives, posing serious health risks ¹¹.

Other ways to stimulate GLP-1 production

Certain nutrients and activities can naturally boost GLP-1 production. Carbohydrates and fats are particularly effective at stimulating its release, and meals with a mix of nutrients are generally more efficient at promoting GLP-1 production than single foods. Exercise is another excellent way to increase GLP-1 levels, adding to its overall health benefits ¹² ¹³ ¹⁴ ¹⁵.

GLP-1 medications work by promoting satiety and helping you feel full for longer. Similarly, you can support satiety naturally by choosing foods with a high satiety index. Whole foods rich in protein, fiber, and whole grains are excellent options. Minimally processed foods are generally more filling and have a lower glycemic impact compared to ultra-processed foods. Among snacks, those higher in protein tend to have the strongest effect on promoting fullness¹⁶ ¹⁷.

It’s also worth noting here that naturally produced GLP-1 breaks down super quickly in your body, while medications like Ozempic are designed to last longer. These medications mimic GLP-1 but resist breakdown, staying effective for days to help regulate appetite and blood sugar.

How to improve Insulin Sensitivity naturally

I won’t dive too deeply into this topic, but GLP-1 medications are known to improve the body’s response to insulin, also called insulin sensitivity. The good news is that you can support this naturally by making lifestyle choices like:

• Choosing low glycemic foods to help maintain stable blood sugar levels.

• Incorporating protein, healthy fats and fiber into your meals, which slow down digestion and reduce blood sugar spikes.

• Exercising regularly, as physical activity is a proven way to enhance insulin sensitivity .

• Managing sleep and stress, since poor sleep and chronic stress can negatively impact insulin function.

• Maintaining a healthy weight, as excess fat, especially around the abdomen, can impair insulin sensitivity. Even losing five to ten percent of your body weight can make a significant difference in improving your insulin sensitivity ¹⁸ ¹⁹ ²⁰.

Other supplements that could influence GLP-1 Levels?

The truth is, most of the so-called "Ozempic miracle" options trending online and on TikTok don’t live up to the hype. Green tea, yerba mate, ginseng, and curcumin have all been labeled as having "Ozempic-like" effects, but the evidence behind these claims is pretty weak. Most of the research comes from animal studies (mice) and test tubes, which doesn’t always translate to humans.

Yerba mate

For example, the results of this study on yerba mate and obesity are based on 14 studies conducted on mice and only 3 on humans. Among the human trials, only one focused on weight loss and reported only minimal effects. Overall, yerba mate might have some modest benefits for obesity, particularly in improving lipid profiles, as seen in both humans and animal models ²¹ ²².

Do I see it as a replacement for Ozempic? Absolutely not. Do I think it’s great for the polyphenols, like chlorogenic and caffeic acids, which provide antioxidant benefits and may help lower blood glucose levels? Absolutely yes.

Green tea

Green tea does have a lot of benefits and definitely deserves a place in your daily diet. Plus, it’s a great alternative to coffee. It’s packed with antioxidants and might offer modest benefits, such as improving blood sugar control, supporting healthy cholesterol levels, and boosting metabolic health in people with type 2 diabetes ²³ ²⁴ ²⁵.

While it’s not "Ozempic magic," it’s still a solid choice to include in your routine.

The Verdict!

Berberine has some potential health benefits and modest weight loss effects, but it does not compare to the effectiveness of GLP-1 medications like Ozempic or Wegovy (NOTHING nothing currently matches the effectiveness of GLP-1 medications). While it is natural, that does not automatically make it healthier or better. Moreover the research on berberine is inconsistent and often of low quality, with many studies conducted on animals or small groups of people.

Even if berberine were proven effective, taking a supplement for weight loss will not address the habits or root causes that led to weight gain. Relying on supplements alone is like placing a small bandage on a much larger issue, offering a quick fix without tackling the deeper problem.

Also, funny enough, I have not seen any berberine fans talking about its poor bioavailability. It does not dissolve well in water, and when taken by mouth, only a small amount, about 1% and even less, gets absorbed into the bloodstream ²⁶.  If you want to go ahead with taking berberine, make sure it is from a trusted source and consult your doctor first, especially if you are pregnant, breastfeeding, have medical conditions, or are taking other medications.

TL;DR: Berberine is not a substitute for GLP-1 medications. Be cautious and consult a healthcare professional before trying it. And please, stop taking health advice from social media influencers.

---

P.S. Looking for a sustainable approach to weight management, gut health, and overall wellness? As a registered nutritionist (ANutr) with a BSc in Human Nutrition, I’m here to help!

I look forward to helping you thrive!

Mia

Curious to learn more ? These articles cover related topics to keep you informed:

References (to geek out further):

1.Nhan Trong Le, et al. “Green Extraction of Berberine from Coscinium Fenestratum (Gaertn.) Colebr. Using Ultrasound-Assisted Aqueous Solutions of Organic Acids, Polyalcohols, and Deep Eutectic Solvents.” Separation and Purification Technology, vol. 330, 1 Feb. 2024, pp. 125541–125541, https://doi.org/10.1016/j.seppur.2023.125541.

2.Zhao, Xin, et al. “GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.” Frontiers in Endocrinology, vol. 12, 23 Aug. 2021, https://doi.org/10.3389/fendo.2021.721135.

3.Wang, Qun, et al. “The New Role of AMP-Activated Protein Kinase in Regulating Fat Metabolism and Energy Expenditure in Adipose Tissue.” Biomolecules, vol. 11, no. 12, 1 Dec. 2021, p. 1757, www.mdpi.com/2218-273X/11/12/1757/htm#B92-biomolecules-11-01757, https://doi.org/10.3390/biom11121757. Accessed 10 Dec. 2021.

4.Zheng, Zhikai, et al. “Glucagon-like Peptide-1 Receptor: Mechanisms and Advances in Therapy.” Signal Transduction and Targeted Therapy, vol. 9, no. 1, 18 Sept. 2024, pp. 1–29, www.nature.com/articles/s41392-024-01931-z, https://doi.org/10.1038/s41392-024-01931-z.

5.Asbaghi, Omid, et al. “The Effect of Berberine Supplementation on Obesity Parameters, Inflammation and Liver Function Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Clinical Nutrition ESPEN, vol. 38, Aug. 2020, pp. 43–49, https://doi.org/10.1016/j.clnesp.2020.04.010.

6.Cao, Changfu, and Meiqing Su. “Effects of Berberine on Glucose-Lipid Metabolism, Inflammatory Factors and Insulin Resistance in Patients with Metabolic Syndrome.” Experimental and Therapeutic Medicine, vol. 17, no. 4, 2019, pp. 3009–3014, www.ncbi.nlm.nih.gov/pubmed/30936971, https://doi.org/10.3892/etm.2019.7295.

7.Koppen, Laura M., et al. “Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review.” Journal of Evidence-Based Complementary & Alternative Medicine, vol. 22, no. 4, 16 Jan. 2017, pp. 956–968, https://doi.org/10.1177/2156587216687695. Accessed 6 June 2021.

8.Xie, Liangzhen, et al. “The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials.” Evidence-Based Complementary and Alternative Medicine, vol. 2019, 13 Dec. 2019, pp. 1–14, https://doi.org/10.1155/2019/7918631.

9.Qin, Wenhui, et al. “Efficacy and Safety of Semaglutide 2.4 Mg for Weight Loss in Overweight or Obese Adults without Diabetes: An Updated Systematic Review and Meta‐Analysis Including the 2‐Year STEP 5 Trial.” Diabetes, Obesity and Metabolism, vol. 26, no. 3, 28 Nov. 2023, https://doi.org/10.1111/dom.15386.

10.Gao, Xueqin, et al. “Efficacy and Safety of Semaglutide on Weight Loss in Obese or Overweight Patients without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Frontiers in Pharmacology, vol. 13, 14 Sept. 2022, p. 935823, www.ncbi.nlm.nih.gov/pmc/articles/PMC9515581/, https://doi.org/10.3389/fphar.2022.935823.

11.Guo, Ying, et al. “Repeated Administration of Berberine Inhibits Cytochromes P450 in Humans.” European Journal of Clinical Pharmacology, vol. 68, no. 2, 26 Aug. 2011, pp. 213–217, https://doi.org/10.1007/s00228-011-1108-2.

12.Åkerström, Tobias, et al. “Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women.” Journal of the Endocrine Society, vol. 6, no. 9, 26 July 2022, https://doi.org/10.1210/jendso/bvac111.

13.Nalini Sodum, et al. “Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion.” International Journal of Molecular Sciences, vol. 25, no. 2, 16 Jan. 2024, pp. 1087–1087, pmc.ncbi.nlm.nih.gov/articles/PMC10816371/#, https://doi.org/10.3390/ijms25021087. 

14.Hjørne, Anna Pii, et al. “The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion.” Metabolites, vol. 12, no. 5, 7 May 2022, p. 420, https://doi.org/10.3390/metabo12050420. Accessed 21 Oct. 2022.

15.Hira, Tohru, et al. “Improvement of Glucose Tolerance by Food Factors Having Glucagon-like Peptide-1 Releasing Activity.” International Journal of Molecular Sciences, vol. 22, no. 12, 21 June 2021, p. 6623, www.ncbi.nlm.nih.gov/pmc/articles/PMC8235588/, https://doi.org/10.3390/ijms22126623. Accessed 27 Mar. 2023.

16.A, Fardet. “Minimally Processed Foods Are More Satiating and Less Hyperglycemic than Ultra-Processed Foods: A Preliminary Study with 98 Ready-To-Eat Foods.” Food & Function, 18 May 2016, pubmed.ncbi.nlm.nih.gov/27125637/.

17.Njike, Valentine Yanchou, et al. “Snack Food, Satiety, and Weight.” Advances in Nutrition, vol. 7, no. 5, 1 Sept. 2016, pp. 866–878, www.ncbi.nlm.nih.gov/pmc/articles/PMC5015032/, https://doi.org/10.3945/an.115.009340.

18.Weickert, Martin O. “What Dietary Modification Best Improves Insulin Sensitivity and Why?” Clinical Endocrinology, vol. 77, no. 4, 11 Sept. 2012, pp. 508–512, https://doi.org/10.1111/j.1365-2265.2012.04450.x.

19.Lin, Yi-Hsin, and Hsuan Huang. “Eight-Week of Low-Intensive Lifestyle Modification Does Improve Insulin Resistance in Adults with Metabolic Syndrome.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol. Volume 12, May 2019, pp. 613–621, https://doi.org/10.2147/dmso.s201526.

20.Li, Mengwei, et al. “Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy.” Signal Transduction and Targeted Therapy, vol. 7, no. 1, 6 July 2022, pp. 1–25, www.nature.com/articles/s41392-022-01073-0, https://doi.org/10.1038/s41392-022-01073-0.

21.Gambero, Alessandra, and Marcelo Ribeiro. “The Positive Effects of Yerba Maté (Ilex Paraguariensis) in Obesity.” Nutrients, vol. 7, no. 2, 22 Jan. 2015, pp. 730–750, https://doi.org/10.3390/nu7020730.

22.Graziela Alessandra Klein, et al. “Mate Tea (Ilex Paraguariensis) Improves Glycemic and Lipid Profiles of Type 2 Diabetes and Pre-Diabetes Individuals: A Pilot Study.” Journal of the American College of Nutrition , vol. 30, no. 5, 1 Oct. 2011, pp. 320–332, https://doi.org/10.1080/07315724.2011.10719975.

23.Asbaghi, Omid, et al. “Effect of Green Tea on Anthropometric Indices and Body Composition in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.” Complementary Medicine Research, 18 Nov. 2020, pp. 1–8, https://doi.org/10.1159/000511665.

24.Liu, Chia-Yu, et al. “Effects of Green Tea Extract on Insulin Resistance and Glucagon-like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, Double-Blinded, and Placebo-Controlled Trial.” PLoS ONE, vol. 9, no. 3, 10 Mar. 2014, p. e91163, https://doi.org/10.1371/journal.pone.0091163.

25.Wu, Anna H., et al. “Effect of 2-Month Controlled Green Tea Intervention on Lipoprotein Cholesterol, Glucose, and Hormone Levels in Healthy Postmenopausal Women.” Cancer Prevention Research, vol. 5, no. 3, 1 Mar. 2012, pp. 393–402, cancerpreventionresearch.aacrjournals.org/content/5/3/393.short, https://doi.org/10.1158/1940-6207.CAPR-11-0407.

26.Patel, Parth. “A Bird’s Eye View on a Therapeutically “Wonder Molecule”: Berberine.” Phytomedicine Plus, vol. 1, no. 3, Aug. 2021, p. 100070, https://doi.org/10.1016/j.phyplu.2021.100070.